Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and lysophosphatidylcholines

quinoxalines has been researched along with lysophosphatidylcholines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flavahan, NA1
Kamata, K; Suenaga, H2
Kamata, K; Kobayashi, T; Matsumoto, T1

Other Studies

4 other study(ies) available for quinoxalines and lysophosphatidylcholines

ArticleYear
Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
    The American journal of physiology, 1993, Volume: 264, Issue:3 Pt 2

    Topics: Adenosine Diphosphate; Animals; Bradykinin; Brimonidine Tartrate; Coronary Vessels; Dinoprost; Endothelium, Vascular; Female; Fluorides; GTP-Binding Proteins; Lysophosphatidylcholines; Male; Muscle Contraction; Pertussis Toxin; Quinoxalines; Serotonin; Signal Transduction; Swine; Virulence Factors, Bordetella

1993
Lysophosphatidylcholine potentiates vascular contractile responses by enhancing vasoconstrictor-induced increase in cytosolic free Ca2+ in rat aorta.
    European journal of pharmacology, 1998, Nov-20, Volume: 361, Issue:2-3

    Topics: Animals; Aorta; Brimonidine Tartrate; Calcium; Cytosol; Enzyme Inhibitors; Lysophosphatidylcholines; Male; Naphthalenes; Nicardipine; Norepinephrine; Potassium Chloride; Protein Kinase C; Quinoxalines; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

1998
Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.
    British journal of pharmacology, 2002, Volume: 135, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Genistein; Lysophosphatidylcholines; Male; Muscle Contraction; Phosphorylation; Potassium; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Wistar; Vasoconstrictor Agents

2002
Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
    British journal of pharmacology, 2006, Volume: 149, Issue:7

    Topics: Animals; Aorta, Thoracic; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Lysophosphatidylcholines; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Potassium; Protein Kinase Inhibitors; Protein Tyrosine Phosphatases; Quinoxalines; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptors, G-Protein-Coupled; RNA, Messenger; Up-Regulation; Vanadates; Vasoconstriction; Vasoconstrictor Agents

2006